Study on Avandia by GlaxoSmithKline Questioned by Physicians
A recently released clinical study intended to test whether GlaxoSmithKline PLC's diabetes drug Avandia may be harmful to the heart appears to have raised more questions than it has answered, as some doctors claim that the study is flawed.
Safety concerns have troubled Avandia since 2007, when an analysis of the ...
